encyclopedia of medical concepts
ψ 
ψ 
ψ 
ψ 

Cyclin-Dependent Kinase Inhibitor p57

More information in Books or onNLM PubMed
Definition: A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME.     
Pharmacological Action Protein Kinase Inhibitors 		Other names KIP2 Protein, p57; Cyclin Dependent Kinase Inhibitor p57; Cyclin Dependent Kinase Inhibitor 1C; p57KIP2 Protein; p57 KIP2 Protein; Cyclin-Dependent Kinase Inhibitor 1C; Cyclin Kinase Inhibitor Protein 2; CDKN1C Protein
 
SubstanceCAS Registry & nameCategoriesSourceDrugs*
Cdkn1c protein, mouse  0   *Cyclin-Dependent Kinase Inhibitor p57.
CDKN1C protein, human  0   *Cyclin-Dependent Kinase Inhibitor p57.

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy